
Zohydro Capsule, Extended Release (Zogenic, Inc). Wolters Kluwer Clinical Drug Information, Inc. American Society of Health-System Pharmacists (ASHP). McEvoy GK, Snow EK, Miller J et al (eds). Potentially Fatal: Respiratory depression.Īnon.
#Norco drug skin
Skin and subcutaneous tissue disorders: Rash, pruritus, hyperhidrosis, night sweats. NORCO ® (Hydrocodone bitartrate and acetaminophen) is supplied in tablet form for oral administration.
#Norco drug professional
Warning Serious side effects Other side effects Professional info FAQ Note: This document contains side effect information about acetaminophen / hydrocodone. Respiratory, thoracic and mediastinal disorders: Bronchitis, nasal congestion, nasopharyngitis, oropharyngeal pain, sinusitis, upper respiratory tract infection, cough, dyspnoea. Norco Side Effects Generic name: acetaminophen / hydrocodone Medically reviewed by. Psychiatric disorders: Euphoria, dysphoria, anxiety, insomnia, depression. Nervous system disorders: Dizziness, headache, chills, migraine, paresthesia. Musculoskeletal and connective tissue disorders: Back pain, muscle spasm, tremor, arthralgia, bone fracture, injury to the joint, joint sprain, limb pain, musculoskeletal pain, myalgia, neck pain, osteoarthritis, chills. Metabolism and nutrition disorders: Dehydration, hypokalaemia, increased appetite Investigations: Increased gamma-glutamyl transferase, increased cholesterol. General disorders and administration site conditions: Fever, fatigue. Gastrointestinal disorders: Nausea, vomiting, dyspepsia, gastroenteritis, upper abdominal pain, diarrhoea, abdominal pain, decreased appetite, xerostomia, abdominal distress, GERD. Significant: QT prolongation, constipation, severe hypotension (including orthostatic hypotension, syncope), sedation. Refer to individual product for detailed guidelines.Įlderly: Initiate at the lower end of dosing range, with careful titration. Opioid-resistant patients: Initial daily dose is based on the daily opioid requirement for conversion, initial daily dose should be based on the guide that 10 mg of hydrocodone is equivalent to approx 15 mg of oral morphine.

Max: 80 mg daily (only for patients with established opioid tolerance). Dose may be adjusted in increments of 10-20 mg every 3-5 days. As hydrocodone bitartrate extended-release tab: 20 mg once daily (every 24 hours). Dose can be adjusted in increments of 10 mg bid every 3-7 days. Opioid-naive or opioid non-tolerant patients: As hydrocodone bitartrate extended-release cap: Usual initial dose: 10 mg bid (every 12 hours). Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Adult: Initial dosages are individualised based on severity of pain, prior analgesic use and risk factors for addiction, abuse, or misuse.
